Actinium Pharmaceuticals announced inducement equity awards for its new CFO, Dr. Matt David, and new Senior VP of Business Development, Sean Maenpaa. Dr. David received options to buy 250,000 shares at $0.97 each and 250,000 restricted stock units (RSUs), with additional milestone-based RSUs. Mr. Maenpaa was granted options for 40,000 shares at $1.06 each and 70,000 RSUs, some tied to corporate milestones. These awards aim to attract and retain key executives as Actinium advances its cancer-targeted radiotherapy programs.
Actinium Pharmaceuticals announced inducement grants to new executives as context for readers. For readers following the Health sector, here is Pluang's market snapshot as of Oct 17, 2026 03:11 WIB: out of 150 priced US Health stocks, 52 rose and 98 fell. Notable movers include Sana Biotechnology Inc (SANA) at USD 2.25 with a 1-day change of -8.89%, Twist Bioscience Corp (TWST) at USD 132.40 down 8.37%, and TransMedics Group Inc (TMDX) at USD 70.18 down 8.29%.
Changan Automobile announced new partnerships covering seven European markets and launched its "with U" service program at Mondial de l’Auto 2026. This marks a shift from market entry to building a local ecosystem including manufacturing, sales, serv...
At the 2026 Mondial de l’Auto, Changan Automobile signed letters of intent with eight companies across seven European markets and launched its "with U" service program. This marks a strategic move to build a strong local ecosystem combining manufactu...
Northland Power Inc. announced it will release its third quarter 2026 financial results after market close on November 12, 2026. The company will host an earnings call and webcast on November 13 at 9:00 a.m. ET, providing investors an opportunity to ...
Several daily leveraged ETFs tied to tech and crypto-related stocks dropped sharply, with declines over 20%. Notable falls include GraniteShares 2x Long NBIS Daily ETF down 24.5% and Leverage Shares 2x Long CRWV Daily ETF down 23.9%. These ETFs aim t...
Recent biotech IPOs Iambic Therapeutics and City Therapeutics saw significant price jumps, rising 25.9% and 22.2% respectively after their market debuts, raising substantial capital. Inverse leveraged ETFs SMCZ and SMST also gained sharply as their u...
